Table 2 Two-factor main effects ANOVA model results on gait measures.

From: The cyclophilin inhibitor NIM-811 increases muscle cell survival with hypoxia in vitro and improves gait performance following ischemia–reperfusion in vivo

Gait measure

Variable

Level

Mean

SD

F

p-value

Distance

Sex

Female

13.90

4.78

0.69

0.4178

Male

12.23

4.73

Treatment

Control

11.27

3.83

3.22

0.0905

NIM-811

14.87

4.99

Speed

Sex

Female

0.19

0.11

0.38

0.5484

Male

0.16

0.18

Treatment

Control

0.09

0.07

10.31

0.0051

NIM-811

0.26

0.15

Gait score

Sex

Female

2.30

0.82

0.34

0.5675

Male

2.10

0.99

Treatment

Control

1.70

0.67

8.50

0.0096

NIM-811

2.70

0.82

Back to article page